Home › Shire to buy New Jersey-based NPS Pharma is $5.2B deal
 

Keywords :   


Shire to buy New Jersey-based NPS Pharma is $5.2B deal

2015-01-11 19:19:23| Biotech - Topix.net

Less than two months after announcing its U.S. headquarters will be in Massachusetts, Shire Pharmaceuticals is buying a New Jersey-based maker of gastrointestinal drugs, NPS Pharma for $5.2 billion. The purchase price represents a 51 percent premium to the share price of NPS when reports of the pending deal first emerged on Dec. 16, and is 9 percent higher than it's stock as of Friday's close.

Tags: buy deal pharma shire

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
11.05YouGov Unveils Americans Skincare Routines
11.05Naples Soap Company Reports Revenue Surge Amidst Tourist Season
11.05Indian Perfume Brand Eze Perfumes Enters US Market
11.05LOccitane Travel Retail Showcases Travel Retail Brand Portfolio at TFWA Asia Pacific
10.05How crops are being disaster-proofed
10.05'I got married on a Thursday and saved 3,000'
10.05Inland Packaging receives Molson Coors Packaging Supplier of the Year
10.05Delays warning as M25 stretch closes for the weekend
More »